ImmuCell Corporation Repayments of Bank Debt
ImmuCell Corporation (ICCC) reported Repayments of Bank Debt of $2.65 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfBankDebt · last filed 2025-11-13
- ImmuCell Corporation repayments of bank debt for the quarter ending 2025-09-30 was $2.65M, a 619.67% increase year-over-year.
- ImmuCell Corporation repayments of bank debt for the quarter ending 2025-06-30 was $381.44K, a 4.69% increase year-over-year.
- ImmuCell Corporation repayments of bank debt for the quarter ending 2025-03-31 was $380.11K, a 5.15% increase year-over-year.
- ImmuCell Corporation repayments of bank debt for the quarter ending 2024-12-31 was $374.23K, a 4.90% increase year-over-year.
| Period end | Repayments of Bank Debt 3 month | Repayments of Bank Debt 6 month | Repayments of Bank Debt 9 month | Repayments of Bank Debt 12 month |
|---|---|---|---|---|
| 2025-09-30 | $2.65M 10-Q · filed 2025-11-13 | $3.03M derived: sum of 2 quarters · filed 2025-11-13 | $3.41M 10-Q · filed 2025-11-13 | $3.79M derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-06-30 | $381.44K 10-Q · filed 2025-08-14 | $761.54K 10-Q · filed 2025-08-14 | $1.14M derived: sum of 3 quarters · filed 2025-11-13 | $1.50M derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-03-31 | $380.11K 10-Q · filed 2025-05-14 | $754.34K derived: sum of 2 quarters · filed 2025-11-13 | $1.12M derived: sum of 3 quarters · filed 2025-11-13 | $1.49M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-12-31 | $374.23K derived: 10-Q 12 month − 10-Q 9 month · filed 2025-11-13 | $742.48K derived: sum of 2 quarters · filed 2025-11-13 | $1.11M derived: sum of 3 quarters · filed 2025-11-13 | $1.47M 10-Q · filed 2025-11-13 |
| 2024-09-30 | $368.25K 10-Q · filed 2025-11-13 | $732.60K derived: sum of 2 quarters · filed 2025-11-13 | $1.09M 10-Q · filed 2025-11-13 | $1.45M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $364.35K 10-Q · filed 2025-08-14 | $725.86K 10-Q · filed 2025-08-14 | $1.08M derived: sum of 3 quarters · filed 2025-11-13 | $1.41M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-03-31 | $361.51K 10-Q · filed 2025-05-14 | $718.26K derived: sum of 2 quarters · filed 2025-11-13 | $1.04M derived: sum of 3 quarters · filed 2025-11-13 | $1.30M derived: sum of 4 quarters · filed 2025-11-13 |
| 2023-12-31 | $356.76K derived: 10-Q 12 month − 10-Q 9 month · filed 2025-11-13 | $682.50K derived: sum of 2 quarters · filed 2025-11-13 | $934.40K derived: sum of 3 quarters · filed 2025-11-13 | $1.19M 10-Q · filed 2025-11-13 |
| 2023-09-30 | $325.74K 10-Q · filed 2024-11-13 | $577.64K derived: sum of 2 quarters · filed 2024-11-13 | $829.01K 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $251.90K 10-Q · filed 2024-08-13 | $503.28K 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | $251.38K 10-Q · filed 2024-05-14 | |||
| 2022-12-31 | $897.13K 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |